Cannell & Co. Merrimack Pharmaceuticals Inc Transaction History

Cannell & Co.

$3.01 Billion
Q4 2023

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 12, 2019	SELL	$4.39 - $5.66 $219,324 - $282,773	-49,960 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$2.95 - $4.15 $74,950 - $105,439	-25,407 Reduced 33.71%	49,960 $193,000
Q1 2018 May 09, 2018	SELL	$6.24 - $9.15 $624 - $915	-100 Reduced 0.13%	75,367 $607,000
Q4 2017 Feb 13, 2018	SELL	$7.99 - $11.87 $88,673 - $131,733	-11,098 Reduced 12.82%	75,467 $774,000
Q3 2017 Nov 08, 2017	BUY	$9.13 - $11.72 $790,338 - $1.01 Million	86,565	86,565 $1.26 Million

Others Institutions Holding MACK

# of Institutions

1

Shares Held

77

Call Options Held

0

Put Options Held

0

Farther Finance Advisors, LLC San Francisco, CA

77
Shares

$1,165
0.0% of portfolio

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.